MA Programme definition

MA Programme means the Modern Apprentice programme managed by SDS, the details of which are set out in the Programme Contract for Modern Apprenticeships, and as published on the SDS website.
Sample 1Sample 2
MA Programme or “Programme” means the Modern Apprenticeship Programme funded by SDS Section A - Apprentice Details First Name Middle Name Last Name Date of Birth National Insurance (NI) Number Scottish Candidate Number (SCN) Email Address Mobile Phone Number Home Phone Number Preferred Method of Contact SMS Text. or Email Postcode Address Line 1 Address Line 2 Town / City County
Sample 1

Examples of MA Programme in a sentence

  • Should the best student not be enrolled on the MA Programme, the next best graduate, with a first class, enrolling on the MA Programme will become the beneficiary.

  • You must use your best efforts to encourage each Apprentice to register on our My World of Work web service at http://www.myworldofwork.co.uk/ (or any alternative address that we may use from time to time) during the Apprentice’s induction to the MA Programme and, if unsuccessful at that time, during the Apprentice’s training.

  • In deciding who is eligible for recruitment to the MA Programme, you must apply such additional or alternative eligibility criteria as we may inform you about in line with the MA Conditions.

  • Following expiry or earlier termination of the MA Contract, you shall not represent that you are contracted to provide training under the MA Programme and you shall not, even if previously permitted to do so, use or continue to use any SDS branding.

  • You must conform to all marketing and brand guidelines and standard marketing literature that we issue in relation to the MA Programme.

  • You cannot make any charge of any nature to any Apprentice or proposed Apprentice, or former Apprentice, in respect of the MA Programme, whether before, during or after the individual’s participation in the MA Programme.

  • You must always have in place management processes and controls to ensure that: you are meeting your contracted obligations; all your Staff involved with the MA Programme are aware of all its requirements; you promptly identify and disclose to us any actual or potential conflict of interest; and there is clear segregation of duties that provide a check that the MA Programme Specification and Conditions are followed.

  • You will use only approved programme names in communications with targeted Apprentices and actual Apprentices in relation to the MA Programme.

  • You undertake (i) to organise the delivery of the MA Programme in such a way that there will be no organised grouping of your employees which has as its principal purpose delivery of the MA Programme and (ii) that where such a grouping exists, to ensure that any such employees are redeployed elsewhere within your organisation (or your subcontractor as the case may be) prior to termination, expiry or any reduction in scope of the MA Contract.

  • Funding for each MA Programme will be administered through FIPS in line with our requirements.

Related to MA Programme

  • Programme means any television broadcast and includes-

  • the Programme means the Government programme for delivery of smart metering in Great Britain. The Programme is responsible for overseeing the development and implementation of policy, including establishing the commercial and regulatory framework to facilitate the roll-out;

  • CRAF Program means the Civil Reserve Air Fleet Program authorized under 10 U.S.C. Section 9511 et seq. or any similar or substitute program under the laws of the United States.

  • Development Program means the implementation of the development plan.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Learning Programme means a programme of education and/or training delivered by the Provider under this Agreement;

  • Collaborative pharmacy practice agreement means a written and signed

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • Research Program has the meaning set forth in Section 2.1.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • E-Verify Program above means the employment verification program administered by the United States Department of Homeland Security, the Social Security Administration, or any successor program.

  • AML Program has the meaning ascribed thereto in Schedule 2.1(F)(8) hereof.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Development Plan has the meaning set forth in Section 3.2.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Maintenance Programme shall have the meaning set forth in Clause 14.3; “Maintenance Period” shall have the meaning set forth in Clause 14.1; “Maintenance Requirements” shall have the meaning set forth in Clause 14.2;

  • Video programmer means a person or entity that provides video programming to end-user

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Training program means a standardized medication

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Development Plans has the meaning set forth in Section 3.2.